The Traderszone Network

Published in TZ Latest News 13 April, 2016 by The TZ Newswire Staff

What Caused Arrowhead Pharmaceuticals to Skyrocket 13% Today

New data from its trial of ARC-520 in hepatitis B ignited a rally.